Citius Pharma raises ~$3M in registered direct offering of stock and warrants

Citius Pharmaceuticals, Inc.

Offering of 743,496 shares plus warrants for 743,496 shares at combined price of $4.035 per unit.
Warrants exercisable at $4.035/share (8-K) or $3.91/share (press release), expire in 5 years.
Net proceeds ~$2.7M after fees; intended for clinical development and working capital.
H.C. Wainwright placement agent with 7% cash fee, $50k legal, $35k expense, and 52,045 placement agent warrants at $5.0438.
Offering closed January 8, 2025 under effective shelf registration statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.